Cargando...
Regarding “Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies”
This editorial reflects on improvements in the cancer drug approval process of the U.S. Food and Drug Administration.
Gardado en:
| Publicado en: | Oncologist |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AlphaMed Press
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5507657/ https://ncbi.nlm.nih.gov/pubmed/28576859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0202 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|